SNN Stock Summary and Trading Ideas (Smith & Nephew Snats | NYSE:SNN)

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Smith & Nephew Snats trades on the NYSE stock market under the symbol SNN.

As of March 13, 2026, SNN stock price declined to $32.96 with 535,978 million shares trading.

SNN has a beta of 0.75, meaning it tends to be less sensitive to market movements. SNN has a correlation of 0.23 to the broad based SPY ETF.

SNN has a market cap of $13.98 billion. This is considered a Large Cap stock.

In the last 3 years, SNN traded as high as $38.79 and as low as $21.53.

The top ETF exchange traded funds that SNN belongs to (by Net Assets): AVDE, BINV, DFIC, KOMP, DFAX.

SNN has underperformed the market in the last year with a price return of +16.9% while the SPY ETF gained +19.8%. However, in the short term, SNN had mixed performance relative to the market. It has outperformed in the last 3 months, returning +1.0% vs -2.6% return in SPY. But in the last 2 weeks, SNN shares have been beat by the market, returning -10.1% compared to an SPY return of -3.9%.

SNN support price is $32.45 and resistance is $33.63 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SNN shares will trade within this expected range on the day.